Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report

November 2023 | 54 pages | ID: GA4829ED050EN
MarketLine

Abstracts

Gilead Sciences, Inc. %li%Strategy, SWOT and Corporate Finance Report

Summary

Gilead Sciences, Inc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Gilead Sciences, Inc. (Gilead or 'the company') is a biopharmaceutical company. The company develops and markets medicines for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products under several brand names, including AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vosevi, Zydelig and Sovaldi. Gilead markets its products through commercial teams and in conjunction with third-party distributors and corporate partners. The company sells and distributes most of its products in the US through the wholesale channel. It has business presence in the US, Europe, and other countries. The company is headquartered in Foster City, California, the US.

Scope

• Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
• Intelligence on Gilead Sciences, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Gilead Sciences, Inc.: Company Overview
Gilead Sciences, Inc.: Overview and Key Facts
Gilead Sciences, Inc.: Overview
Gilead Sciences, Inc.: Key Facts
Gilead Sciences, Inc.: Key Employees
Gilead Sciences, Inc.: Key Employee Biographies
Gilead Sciences, Inc.: Major Products and Services
Gilead Sciences, Inc.: Management Statement
Gilead Sciences, Inc.: Locations and Subsidiaries
Gilead Sciences, Inc.: Key Competitors
Gilead Sciences, Inc.: Company Analysis
Gilead Sciences, Inc.: Business Description
Gilead Sciences, Inc.: SWOT Analysis
Gilead Sciences, Inc.: SWOT Overview
Gilead Sciences, Inc.: Strengths
Gilead Sciences, Inc.: Weaknesses
Gilead Sciences, Inc.: Opportunities
Gilead Sciences, Inc.: Threats
Gilead Sciences, Inc.: Corporate Financial Deals Activity
Gilead Sciences, Inc.: Financial Deals Overview
Gilead Sciences, Inc.: Targets and Partners
Gilead Sciences, Inc.: Top Deals 2019 - 2023YTD*
Gilead Sciences, Inc.: Advisors
Gilead Sciences, Inc.: Top Legal Advisors
Gilead Sciences, Inc.: Top Financial Advisors
Gilead Sciences, Inc.: Mergers and Acquisitions
Gilead Sciences, Inc.: Corporate Venturing
Gilead Sciences, Inc.: Capital Raising
Gilead Sciences, Inc.: Partnership
Gilead Sciences, Inc.: Divestments
Gilead Sciences, Inc.: Recent Developments
Gilead Sciences, Inc.: News and Events Summary
Gilead Sciences, Inc.: Contracts
Gilead Sciences, Inc.: Market Developments
Gilead Sciences, Inc.: Research & Development
Gilead Sciences, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Gilead Sciences, Inc.: Key Facts
Table 2: Gilead Sciences, Inc.: Key Employees
Table 3: Gilead Sciences, Inc.: Locations and Subsidiaries
Table 4: Gilead Sciences, Inc.: Key Competitors
Table 5: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Table 7: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Gilead Sciences, Inc.: Targets and Partners
Table 10: Gilead Sciences, Inc.: Top Deals 2019 - 2023YTD*
Table 11: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Gilead Sciences, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Gilead Sciences, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Gilead Sciences, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Gilead Sciences, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Gilead Sciences, Inc.: News and Events Summary
Table 23: Gilead Sciences, Inc.: Contracts
Table 24: Gilead Sciences, Inc.: Market Developments
Table 25: Gilead Sciences, Inc.: Research & Development
Table 26: Gilead Sciences, Inc.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Gilead Sciences, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Gilead Sciences, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Gilead Sciences, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Gilead Sciences, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Gilead Sciences, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)